Problems with medication use in the elderly: An Australian perspective

Journal of Pharmacy Practice and Research

Volumn 36, Issue 1, 2006, Pages 58-66

  Elliott, Rohan A ^a,b,c  

^a AUSTIN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANALGESIC AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; BARBITURIC ACID DERIVATIVE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT; CIMETIDINE; COTRIMOXAZOLE; CYCLOOXYGENASE 2 INHIBITOR; CYPROHEPTADINE; DEXTROPROPOXYPHENE; DICYCLOVERINE; HYOSCYAMINE; METHYLDOPA; MIANSERIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOTHIAZINE; PRAZOSIN; PROMETHAZINE; PROPANTHELINE BROMIDE; PSYCHOTROPIC AGENT; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL; UNINDEXED DRUG;

ANXIETY; AUSTRALIA; BLURRED VISION; CONFUSION; CONSTIPATION; DEPRESSION; DIGESTIVE SYSTEM ULCER; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG MEGADOSE; DRUG MONITORING; DRUG SELF ADMINISTRATION; DRUG USE; ELDERLY CARE; EXTRAPYRAMIDAL SYNDROME; FLUID RETENTION; GASTROINTESTINAL HEMORRHAGE; HEALTH PRACTITIONER; HOSPITAL CARE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPONATREMIA; INCONTINENCE; INSOMNIA; INTERPERSONAL COMMUNICATION; IRRITABILITY; LOW DRUG DOSE; MEDICAL CARE; MEMORY DISORDER; NEUTROPENIA; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; RESIDENTIAL CARE; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; TARDIVE DYSKINESIA; TREMOR; UNSTEADINESS; URINARY URGENCY; URINE RETENTION; VERTIGO; XEROSTOMIA;

EID: 33646509224     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2006.tb00889.x     Document Type: Review

References (87)

1. Byles JE, Heinze R, Nair BK, Parkinson L. Medication use among older Australian veterans and war widows. Intern Med J 2003; 33: 388-92.
2. Atkin PA, Veitch PC, Veitch EM, Ogle SJ. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14: 141-52.
3. Cohen I, Rogers P, Burke V, Beilin LJ. Predictors of medication use, compliance and symptoms of hypotension in a community-based sample of elderly men and women. J Clin Pharm Ther 1998; 23: 423-32.
4. Atkin PA, Shenfield GM. How many medications do elderly patients really take? Aust J Hosp Pharm 1993; 23: 109-13.
5. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58: 648-64.
6. Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust 2002; 177: 189-92.
7. Johnson M, Griffiths R, Piper M, Langdon R. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nurs 2005; 22: 36-44.
8. Krass I, Smith C. Impact of medication regimen reviews performed by community pharmacists for ambulatory patients through liaison with general medical practitioners. Int J Pharm Pract 2000; 8: 111-20.
9. Parkes AJ, Coper LC. Inappropriate use of medications in the veteran community: how much do doctors and pharmacists contribute? Aust N Z J Public Health 1997; 21: 469-76.
10. Simons LA, Tett S, Simons J, Lauchlan R, McCallum J, Friedlander Y, et al. Multiple medication use in the elderly. Use of prescription and non-prescription drugs in an Australian community setting. Med J Aust 1992; 157: 242-6.
11. MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust 2006; 184: 27-31.
12. George J, Ioannides-Demos LL, Santamaria NM, Kong DCM, Stewart K. Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease. Med J Aust 2004; 181: 248-51.
13. Roberts MS, King M, Stokes JA, Lynne TA, Bonner CJ, McCarthy S, et al. Medication prescribing and administration in nursing homes. Age Aging 1998; 27: 385-92.
14. Elliott RA, Thomson WA. Assessment of a nursing home medication review service provided by hospital-based clinical pharmacists. Aust J Hosp Pharm 1998; 29: 255-60.
15. Stokes JA, Purdie DM, Roberts MS. Factors influencing PRN medication use in nursing homes. Pharm World Sci 2004; 26: 148-54.
16. Elliott RA, Woodward MC, Oborne CA. Quality of prescribing for elderly inpatients at nine hospitals in Victoria, Australia. J Pharm Pract Res 2003; 33: 110-15.
17. Harris J, Finucane P, Healy D, Bakarich A. Medication use in hospitalized nonagenarians. Intern Med J 2002; 32: 104-7.
18. Stowasser DA, McGuire TM, Petrie GM, Lauchlan RL, Collins DM. Information quality: a major consideration in the development of medication liaison services. Aust J Hosp Pharm 1997; 27: 362-6.
19. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Am J Geriatr Pharmacother 2004; 2: 257-64.
20. Atkin PA, Stringer RS, Duffy JB, Elion C, Ferraris CS, Misrachi SR, et al. The influence of information provided by patients on the accuracy of medication records. Med J Aust 1998; 169: 85-8.
21. Ientile CS, Sorensen L, Lemanksi L, Roberts MS. Complementary medicines use by Australian Veterans. J Pharm Pract Res 2005; 35: 110-1.
22. Mant A, Kehoe L, Cockayne NL, Kaye KI, Rotem WC. A quality use of medicines program for continuity of care in therapeutics from hospital to community. Med J Aust 2002; 177: 32-4.
23. Flick DM, Cooper JW, Wade WE, Waller JL, MacLean R, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-24.
24. Sorensen L, King MA, Peck R, Roberts MS. In-home medication reviews for war veterans: early experience in Australia. J Pharm Pract Res 2004; 34: 122-4.
25. Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002; 42: 847-57.
26. Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P, et al. An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial. BMC Health Serv Res 2004; 4: 6.
27. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000; 160: 777-84.
28. Roughead EE. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract 1999; 19: 19-22.
29. Landsberg PG, Pillans PI, Radford JM. Evaluation of cyclooxygenase 2 inhibitor use in patients admitted to a large teaching hospital. Intern Med J 2003; 33: 225-8.
30. Jorm AF, Grayson D, Creasey H, Waite L, Broe GA. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 2000; 24: 7-10.
31. Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 2004; 13: 83-7.
32. Roughead EE, Semple SJ, Gilbert AL. Quality use of medicines in aged-care facilities in Australia. Drugs Aging 2003; 20: 643-53.
33. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003; 33: 10-3.
34. Alderman CP, Farmer C. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract 2001; 21: 99-103.
35. Mukasa D, Hughes J. Drug interactions in the elderly: frequency, significance and differences among standard reference resources. Aust Pharmacist 2002; 21: 603-8.
36. Pellizzer A, O'Callaghan CJ, Branley P, Thomson B, Krum H. Polypharmacy in a major Australian teaching hospital. Aust J Hosp Pharm 1998; 28: 432-5.
37. Griffiths R, Johnson M, Piper M, Langdon R. A nursing intervention for the quality use of medicines by elderly community clients. Int J Nurs Pract 2004; 10: 166-76.
38. Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C. Chang JT, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004: 140: 714-20.
39. Gurwitz JH, Rochon P. Improving the quality of medication use in elderly-patients. A not-so-simple prescription. Arch Intern Med 2002; 162: 1670-2.
40. Boyles PJ, Peterson GM, Bleasel MD, Vial JH. Undertreatment of congestive heart failure in an Australian setting. J Clin Pharm Ther 2004; 29: 15-22.
41. Scott IA, Denaro CP, Flores JL, Bennett CJ, Hickey AC, Mudge AM, et al. Quality of care of patients hospitalized with congestive heart failure. Intern Med J 2003; 33: 140-51.
42. McNamara KS, Peterson GM, Friesen WT. Changes in the management of acute myocardial infarction in Southern Tasmania. J Clin Pharm Ther 2000; 25: 111-8.
43. Scott IA, Duke AB, Darwin IC, Harvey KH, Jones MA. Variations in indicated care of patients with acute coronary syndromes in Queensland hospitals. Med J Aust 2005; 182: 325-30.
44. Stewart FM, Singh Y, Persson S, Gamble GD, Braatvedt GD. Atrial fibrillation: prevalence and management in an acute general medical unit. Aust N Z J Med 1999;29:51-8.
45. Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australas J Ageing 2002; 21: 36-41.
46. Evans A, Davis S, Kilpatrick C, Gerraty R, Campbell D, Greenberg P. The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable. J Clin Neuroscience 2002; 9: 268-72.
47. Bradshaw PJ, Jamrozik K, Gilfillan I, Thompson PL. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study. Am Heart J 2004; 147: 1047-53.
48. Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and underrated. Med J Aust 2004; 180: S18-S22.
49. Learhinan ER, Alderman CP. Venous thromboembolism prophylaxis in a South Australian teaching hospital. Ann Pharmacother 2003; 37: 1398-402.
50. McClean WJ, Higginbotham NH. Prevalence of pain among nursing home residents in rural New South Wales. Med J Aust 2002; 177: 17-20.
51. Nair B, Byles J. Immunisation rates in older veterans and war widows. Australas J Ageing 2000; 19: 136-8.
52. Simon SR, Andrade SE, Ellis JL, Nelson WW, Gurwitz JH, Lafata JE, et al. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organisation enrollees. J Am Geriatr Soc 2005; 53: 2165-9.
53. Hurley JS, Roberts M, Solberg LI, Gunter MJ, Nelson WW, Young L, et al. Laboratory safety monitoring of chronic medications in ambulatory care settings. J Gen Intern Med 2005; 20: 331-3.
54. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-16.
55. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38: 303-12.
56. Stewart S, Pearson S. Uncovering a multitude of sins: medication management in the home post acute hospitalisation among the chronically ill. Aust N Z J Med 1999; 29: 220-7.
57. Thompson S, Stewart K. Prescription medication use practices among non-institutionalised older persons. Int J Pharm Pract 2001; 9: 141-51.
58. Hopkins H, Wade T, Weir D. 'Take as directed', whatever that means. Aust Prescr 2000; 23: 103-4.
59. Kippen S, Fraser M, Ellis J. As time goes by: issues for older people with their medication use. Australas J Ageing 2005; 24: 103-7.
60. Bajramovic J, Emmerton L, Tett SE. Perceptions around concordance-focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect 2004; 7: 221-34.
61. Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Aging 2005; 34: 626-32.
62. Sorensen L, King MA, Ientile CS, Roberts MS. Has drug therapy gone to the dogs? Age Aging 2003; 32: 460-1.
63. Peachey KM, Ientile C, Stokes JA, Roberts MS. Are community nursing patients falling through the gaps in medication-related risk reduction strategies? Aust Pharmacist 2004; 23: 398-406.
64. Levings B, Szep S, Helps SC. Towards the safer use of dosettes. J Qual Clin Pract 1999; 19: 69-72.
65. Lim WK, Mason J. The importance of home visits: a case of extreme polypharmacy. Australas J Ageing 2000; 19: 94-5.
66. Roughead EE, Gilbert AL. Primrose JG, Samson LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-8.
67. Burgess CL, Holman CD, Satti AG. Adverse drug reactions in older Australians. 1981-2002. Med J Aust 2005; 182: 267-70.
68. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205.
69. Hewitt J. Drug-related unplanned readmissions to hospital. Aust J Hosp Pharm 1995; 25: 400-3.
70. Australian Council for Safety and Quality in Health Care. Charting the safety and quality of health care in Australia. Canberra: The Council: 2004.
71. Peterson G. Medication usage in the elderly-no signs of improvement. N Z Pharmacy 2005; 25: 25-9.
72. Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998; 46: 174-80.
73. Lau DT, Kasper JD. Potter DEB, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005; 165: 68-74.
74. Gilbert AL, Barratt JD, Roughead EE. Medication management services: alleviating adverse drug reactions [abstract]. Pharmacoepidemiol Drug Saf 2002; 11: S39.
75. Portelli R. Collopy B, Desmond P. Addressing adverse events through clinical indicators. J Qual Clin Pract 1999; 19: 79-83.
76. Pillans PI, Roberts MS. Overprescribing: have we made any progress? Aust N Z J Med 1999; 29: 485-6.
77. Lim WK, Woodward, MC. Improving medication outcomes in older people. Aust J Hosp Pharm 1999; 29: 13-7.
78. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957-9.
79. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716-24.
80. Roughead EE. Managing adverse drug reactions: time to get serious. Identifying these reactions is a good start, now we must focus on managing and preventing them. Med J Aust 2005; 182: 264-5.
81. O'Leary KO, Allinson YM. Pharmacy clinical and distribution service delivery models in Australian public hospitals. J Pharm Pract Res 2004; 34: 114-21.
82. O'Leary KO, Allinson YM, Stowasser DA, Dowling H. Survey of implementation levels and pharmacy requirements for the continuum of quality use of medicines between hospital and community. J Pharm Pract Res 2003; 33: 93-100.
83. Snowdon J. A follow-up survey of psychotropic drug use in Sydney nursing homes. Med J Aust 1999; 170: 299-301.
84. Elliott RA, Woodward MC, Oborne CA. Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing. Age and Aging 2002; 31: 391-6.
85. Chua B, Rochtchina E, Mitchell P. Temporal changes in the control of blood pressure in an older Australian population. J Hum Hypertens 2005; 19: 691-6.
86. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003; 33: 323-8.
87. Moses G. Complementary and alternative medicine use in the elderly. J Pharm Pract Res 2005; 35: 63-8.